Literature DB >> 18302274

Nonresectable carotid body tumor: hybrid surgical procedure to achieve complete and safe resection.

Luis Mauricio Hurtado-Lopez1, Gustavo Fink-Josephi, Luis Ramos-Méndez, Ernesto Dena-Espinoza.   

Abstract

BACKGROUND: Carotid body tumors of Shamblin class III without free internal carotid, between the tumor and skull base, are considered nonresectable. The objective of this work is to describe a surgical technique that combines traditional and endovascular strategies to achieve a safe surgical resection of the carotid body tumor of this class. METHODS AND
RESULTS: A female patient with a nonresectable carotid body tumor underwent placement of an endoprosthesis going from the common carotid artery to the internal carotid beyond the skull base (to secure cerebral circulation) excluding the external carotid artery. Forty-five days later, the tumor was resected without vascular or cranial nerves injury, and bleeding amounted to 50 cm(3). At 6 months, the patient is tumor free and asymptomatic.
CONCLUSION: This is the first known reported case that has been successfully resolved by combining endovascular and traditional strategies. The endoprosthesis maintained cerebral circulation, which otherwise would have been impossible; besides, the vascular supply from the external carotid artery was excluded leading to a decrease in tumor size and a recovery of the sub-adventitial dissection plane, allowing for a successful and safe tumor resection. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18302274     DOI: 10.1002/hed.20808

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  A Hybrid Approach Towards Successful Resection of a Huge Carotid Body Paraganglioma Using Coil Embolization and Traditional Surgical Techniques.

Authors:  T N Janakiram; Joseph Nadakkavukaran; Shilpee Bhatia Sharma; J D Sathyanarayanan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-11-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.